Impact of diagnosis-related group payment on medical expenditure and treatment efficiency on people with drug-resistant tuberculosis: a quasi-experimental study design

Table 3 Impacts of the DRG payment on treatment efficiency among DR-TB patients

	Inpatient frequency	Inpatient LOS per hospitalization	Treatment duration per patient
DID	-1.32* (0.75)	-2.63 days** (1.06)	-25.84 days (39.82)
Control variables	YES	YES	YES
Observations	279	751	279

Standard errors are shown in parentheses. The significance levels of 5%, and 10% are denoted by **, and *, respectively. All regressions controlled individual fixed effects, year fixed effects, and covariates. Covariates include age, sex, marriage status, living area, occupation, drug resistance type, and CCI
DRG: Diagnosis-related group; DID: difference-in-differences; DR-TB: drug-resistant tuberculosis; LOS: length of stay

ISSN: 1475-9276